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Aim: The purpose of this study was to conduct a systematic review of randomized
controlled trials where the efﬁcacy of psychological interventions in modifying
health and behavioural outcomes for adults with asthma was investigated.
Method: A review of randomized controlled trials was designed. The literature
search was conducted until May 2005.
Results: Fourteen studies, involving 617 adults, were included in the review. The
use of ‘as needed’ medications was reduced by relaxation therapy (OR 4.47, CI
1.22–16.44), quality of life, measured using the Asthma Quality of Life Ques-
tionnaire, showed a positive effect following cognitive behavioural therapy (WMD
0.71, CI 0.23–1.19), and peak expiratory ﬂow outcome data indicated a signiﬁcant
difference in favour of bio-feedback therapy (SMD 0.66, CI 0.09–1.23).
Conclusions: Some promising results did emerge from meta-analyses performed.
However, due to heterogeneity and the low quality of included studies, this review
was unable to draw ﬁrm conclusions for the role of psychological interventions in
asthma. We recommend that larger and well-conducted randomized trials use valid
outcome measures to evaluate the effectiveness of psychological interventions for
adults with asthma.
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Asthma has a psychological component, including
emotion,1 so the treatment of asthma in adults
increasingly needs to focus on the whole person,
taking account of psychological as well as physiolo-
gical elements. It is suggested that psychological
interventions may be appropriate for adults with
asthma. Several psychological interventions may be
employed to ameliorate health problems associated
with asthma. These include behavioural therapies,
cognitive therapies, cognitive behavioural therapy,
relaxation techniques, psychodynamic psychothera-
pies, and counselling, in both individual and group
formats. These have been identiﬁed as the proce-
dure by which a therapist systematically attempts to
inﬂuence a patient by psychological means so that
the patient’s symptoms decrease or there is a
positive change in behaviour.2
This means that evidence to support decisions
about the type, format and frequency of psycholo-
gical techniques is needed. The aim of these
strategies is to help reduce panic or fear, improve
breathing and respiratory function and impact
positively on general health and quality of life.
Literature is growing on the relationship between
psychosocial factors and asthma,3,4 and reviewmethodologies are being used to assess the impact
of a range of psychosocial interventions in asthma.
For example, reviews have been undertaken on
self-management education for asthmatic adults,5
psycho-educational interventions for adults and
children,6 family therapy for asthma in children7
and psychological interventions for children with
asthma.8
These reviews do not answer questions speciﬁ-
cally about psychological interventions for adults
with asthma and therefore a systematic review of
the effectiveness of such interventions is also
required. When managing patients, clinical staff
need to have reliable information on whether
psychological techniques work, and if so which
are the most effective, for which patients. Clini-
cally, psychological interventions are required in
medical conditions for general adjustment to the
demands of symptom management and when
psychological factors impede conventional courses
of medical treatment, such as in those patients
with genuine psychopathology. In particular, psy-
chological co-morbidity has been demonstrated to
have high prevalence (49%) in patients referred
with difﬁcult-to-control asthma.9 However, these
same authors also report that psychological co-
morbidity is often not diagnosed.
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tions work best alone or in combination with each
other, and whether it is better that patients are
taught individually or in a group. If possible it would
also be useful for staff and patients to know what
beneﬁts might be expected, and whether they are
short-lived or last in the longer term. Of note,
psychological interventions receive little or no
mention in international guidelines, such as the
British Thoracic Society (BTS),10 Global Initiative
for asthma (GINA)11 for the management of asthma.
Therefore, we conducted a systematic review to
provide health care professionals with an evidence
base in relation to psychological intervention for
adults with asthma.Methods
Objective
The purpose of this study was to conduct a
systematic review and meta-analysis of randomised
controlled trials where the efﬁcacy of psychological
interventions in modifying health and behavioural
outcomes for adults with asthma was investigated.Types of studies
Randomized controlled trials (RCT) comparing the
effects of psychological interventions for adults
with asthma were considered for inclusion. Cross-
over trials were considered inappropriate for
studies using psychological interventions as the
inﬂuence of a treatment might continue after the
intervention has been stopped and were therefore
excluded.
Individual and group formats were included but
patient education programmes were only accepted
where psychotherapy formed the major part of the
intervention. Breathing retraining, yoga and mas-
sage therapies were not incorporated, as these
therapies were not considered to be primarily
psychological in nature.Types of participants
Adults, both male and female, over the age of 16
years of age, with asthma that has been diagnosed
by a physician, although the accuracy can be
variable, or diagnosed using internationally estab-
lished criteria.10 Treatments in both in and out-
patient settings were included.Types of interventions
Psychotherapy models were grouped according to
their theoretical frameworks or methods of opera-
tion.
Approaches included:1. Behavioural therapies.
2. Cognitive therapies.
3. Cognitive behaviour therapy.
4. Relaxation techniques (including progressive
relaxation, autogenic training, hypnosis, and
biofeedback).5. Psychodynamic psychotherapies (including psy-
choanalysis, psychosomatic therapy).6. Counselling.
Approaches excluded:1. Family therapy: this is the subject of another
review recently updated by our group.72. Educational approaches: such approaches are
already the subject of several reviews.5 For this
reason, patient education programmes were
only included where they comprised only part
of a more complex psychological intervention.3. Breathing re-training exercises: a review has
already been completed on this topic.12
Outcome measures
Primary: Health service utilisation (e.g. hospitalisation,
emergency room visits and, GP visits)
Secondary: Asthma symptoms
 Lung function measures
 Medication use
 Absenteeism from school/work
 Psychological health status (e.g. coping skills,
anxiety, depression, asthma related behaviour,
locus of control, self-esteem, self efﬁcacy,
quality of life and psychological status)
Search strategy
The primary source of studies was from the Cochrane
Airways Review Group trials register. In addition, the
psychological database PSYCHINFO was searched. A
detailed description of the search terms applied to
these databases is available in the Cochrane Database
of Systematic Reviews.10 Bibliographies of each trial
identiﬁed were searched for additional relevant
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and asked for information on further published or
unpublished work. All searches were restricted to
cases aged 16 years of age or more. Studies found up
to the end of May 2005 were included.
Study selection
Two reviewers (SF and CS or JY and CS) established
independently whether each study met the inclu-
sion criteria. Disagreements were resolved by
discussion and 14 RCTs were included.
Methodological quality
The methodological quality of the studies (alloca-
tion concealment) was assessed independently by
two reviewers (SF and CS or JY and CS) using
the Cochrane criteria for allocation concealment
(Table 1) and a modiﬁed 0–5 scale developed
by Jadad et al.14 (Table 2). Modiﬁcation of this
scale was essential as, due to the nature of the
psychological interventions, it would be difﬁcult to
conduct double-blinded trials. Therefore in step 2
and 5 ‘double-blind’ has been changed to ‘blind’.
Data analysis
Data were extracted and entered into RevMan 4.2.
For continuous outcomes, we pooled data with a
ﬁxed effect mean difference and 95% conﬁdence
intervals (CIs). Where heterogeneity was present
(40%) we performed a random effects analysis to
incorporate statistical heterogeneity into the
pooled estimate. Where this altered the signiﬁ-
cance of the effect we have reported both sets of
results. Where data were not available as Ns,Table 2 Modiﬁed Jadad scale.3
 Was the study described as randomised (1 ¼ yes;0 ¼ no
 Was the outcome assessment blinded (1 ¼ yes;0 ¼ no)?
 Was there a description of withdrawals and dropouts (1
 Was the method of randomisation well described and a
 Was the method of blinding well described and approp
 Deduct one point if methods for randomisation or blind
Table 1 Allocation concealment.
Grade A: adequate concealment
Grade B: uncertain
Grade C: clearly inadequate concealment
Grade D: not usedmeans and SDs or SEMs, we have attempted to derive
effect estimates based on the mean difference and
an estimate for the variance based upon the
published P value. This was subsequently entered
as generic inverse variance data (GIV).
Dichotomous outcomes were entered as simple
event rates for treatment and control groups. We
pooled data with a ﬁxed effect odds ratio (OR).
Where heterogeneity was present (40%) we per-
formed a random effects analysis to incorporate
statistical heterogeneity in to the pooled estimate.
Where this altered the signiﬁcance of the effect we
have reported both sets of results. For signiﬁcant
outcomes, we calculated a number needed to treat
(beneﬁt) (NNT(b)) or number needed to treat
(harm) (NNT(h)), based upon the OR with Visual Rx.Results
The literature search identiﬁed 85 papers, of which
14 (Table 3) met our inclusion criteria15–29 with two
publications from one study reporting different
outcomes.16,17 All were randomised and conducted
over a variety of durations (3 days–12 months). A
full reference list for excluded papers can be found
in the Cochrane Database of Systematic Reviews.13
Methodological quality of included studies
The methodological quality of the studies was poor
with only two recent studies allocated a Jadad
score of four (Table 3).24,26 Allocation concealment
was often not described (Table 3).
Study participants
A total of 617 participants were included in this
review (Table 3). The studies were generally small
with only one having more than a 100 people
included23 and the smallest had 12.17 In some
studies a description of withdrawals was not
given.15,19,25 Others gave the numbers who with-
drew but no details of their characteristics. The)?
¼ yes;0 ¼ no)?
ppropriate (1 ¼ yes;0 ¼ no)?
riate (1 ¼ yes;0 ¼ no)?
ing were inappropriate.
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Psychological interventions for adults with asthma 7severity of asthma varied from mild to severe,
however not all studies reported this.Method of randomisation
Studies were randomised with patients allocated to
control and experimental groups; however the
method of randomisation was not always men-
tioned.15,19,22,23,25,27 Therefore it is difﬁcult in all
the studies to gauge whether the method of
randomisation was appropriate. This is reﬂected
in the Jadad scores (Table 3).Interventions used
Diverse interventions were used (Table 4). Rarely
was the theoretical underpinning of the therapy
provided. Eight studies used some form of relaxa-
tion technique as their intervention15–19,21,22,29
however techniques ranged from autogenic therapy
to hypnosis and progressive muscle relaxation.
Other psychological interventions included bio-
feedback22,24,25 and CBT.26–28 In asthma, all of
these techniques are used in combination with drug
therapies.Table 4 Effect of psychological interventions on outcom
Study Outcome and effect
Healthcare utilisation
Hospital admission rates
Deter15 
Sommaruga28 +
Emergency room visits
Sommaruga28 +
Asthma symptoms
Asthma Quality of Life Questionnair
Total
Put26 +
Ross27 
Pooled effect +
Epstein16 
Asthma symptom checklist
All variables
Lehrer22 +
Lehrer23 
Hyperventilation
Put26 
Obstruction
Put26 +
Fatigue
Put26
IrritationPrimary outcome
Health service utilisation
Three studies15,28,29 examined this outcome. Deter
and Allert15 found no signiﬁcant decrease in health-
care utilisation in the group receiving relaxation
compared to the control group. Sommaruga et al.28
found numbers of hospitalisation days and number
of emergency visits were decreased for both the
intervention group (an asthma rehabilitation pro-
gramme) and the control group (Po0:05). Numbers
were too small in a study on hypnosis29 to test for
statistical differences for this outcome. Due to
varying interventions and insufﬁcient reporting of
data a pooled effect on the primary outcome could
not be performed.Secondary outcomes
Asthma symptoms
These were measured in a variety of ways in a
number of studies of which ﬁve used a form of
relaxation therapy,16–18,22,29 two used bio-feedback
techniques20,21 and three employed CBT.26–28
The Asthma Quality of Life Questionnaire (AQLQ),30
which includes asthma symptom categories, was
adapted as an outcome measure in three studies. A
meta-analysis could be performed with the two CBTe measures.
Analysis Intervention
Between groups Relaxation therapy
Within group CBT
Within group CBT
e
Between groups CBT
Between groups CBT
Between groups Relaxation therapy
Across all groups Relaxation therapy
Within group Bio-feedback
Between groups CBT
Between groups CBT
Between groups CBT
ARTICLE IN PRESS
Table 4 (continued )
Study Outcome and effect Analysis Intervention
Put26  Between groups CBT
Dyspnoea
Put26  Between groups CBT
Hyperventilation
Put26  Between groups CBT
Anxiety
Put26  Between groups CBT
Home diaries/self report
Sleep
Ewer18 + Within sub-group Relaxation therapy
Wheeze
Ewer18 + Within sub-group Relaxation therapy
Epstein16  Between groups Relaxation therapy
Activity
Ewer18 + Within sub-group Relaxation therapy
Cough
Ewer18  Within sub-group Relaxation therapy
Phlegm
Ewer18  Within sub-group Within sub-group
Other symptom measures
Lehrer24 + Within group Bio-feedback
Lung Function
PEF
Lehrer23  Between groups Bio-feedback
Lehrer22 + Between groups Bio-feedback
Pooled effect +
FEV1
Ewer18  Between groups Relaxation therapy
Henry19  Between groups Relaxation therapy
Epstein16  Between groups Relaxation therapy
Pooled effect 
Payette25  Between groups Bio-feedback
Hockemeyer21  Between groups Bio-feedback
FEV1% predicted
Henry19 + Within group Relaxation therapy
Hockemeyer21  Between groups Bio-feedback
FEV1/FVC
Hockemeyer21 + Between groups Relaxation therapy
Payette25  Between groups Bio-feedback
Medication use
Epstein16  Between groups Relaxation therapy
Wagaman29  Between groups Relaxation therapy
Pooled effect + Within sub-group Relaxation therapy
Ewer18 +
Deter15 + Between groups Relaxation therapy
Lehrer24 + Within group Bio-feedback
Lehrer23  Between groups Bio-feedback
School/work absenteeism
Sommaruga28 + Within group CBT
Psychological Health Status
Anxiety Between groups CBT
Put26 (ASC) Between groups CBT
Ross27 + (SPRAS) Between groups CBT
Ross27 + (number of panic attacks) Between groups CBT
Ross27 + (ASI) Between groups Relaxation therapy
Trait anxiety
Epstein16 —(Spielberger) Between groups Relaxation therapy
J. Yorke et al.8
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Table 4 (continued )
Study Outcome and effect Analysis Intervention
Sommaruga28 + (CBA) Within group CBT
State anxiety
Epstein16 —(Spielberger) Between groups Relaxation therapy
Depression
Epstein16 —(BDI)
Ross27 + (BDI) Between groups CBT
Sommaruga28 + (CBA) Within group CBT
Health locus of control
Sommaruga28  Within group CBT
Respiratory Illness Questionnaire
External control
Sommaruga28 + Within group CBT
Psychological stigma
Sommaruga28 + Within group CBT
Vegetative state
Henry19 + Within group Relaxation therapy
Emotional state
Henry19  Within group Relaxation therapy
Behavioural state
Henry19  Within group Relaxation therapy
Reactivity to stress
Henry19  Within group Relaxation therapy
Negative emotional state
Put26 + Between groups CBT
Perceived Stress Scale
Hockemeyer21  Between groups CBT
Participant satisfaction
Hockemeyer21 + Between groups CBT
Withdrawals
Sommaruga28  Between groups CBT
Put26 
Pooled effect 
Erskine17  Between groups Relaxation therapy
Ewer18 
Hockemeyer21 
Epstein16 
Pooled effect 
+: statistically signiﬁcant effect; : no statistically signiﬁcant effect; CBT: cognitive behavioral therapy; PEF: peak expiratory
ﬂow; FEV1: forced expiratory volume in 1 s; FEV1%: forced expiratory volume in 1 s percent predicted; FEV1/FVC: ratio of forced
expired volume in one second to forced vital capacity; ASC: Asthma Symptom Checklist; SPRAS: Sheehan Patient-Rated Anxiety
Scale; BDI: Beck Depression Index.
Figure 1 Quality of life scores (AQLQ).
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J. Yorke et al.10studies.26,27 This analysis indicated a signiﬁcant
difference in favour of CBT for the Total AQLQ
(WMD 0.71, CI 0.23–1.19) (Fig. 1). One study16 found
no signiﬁcant improvement in the relaxation group
with a Total AQLQ mean 5.25 (SD 1.39) compared to
the control group mean 4.89 (SD 1.45) (data available
through author correspondence).
The Asthma Symptom Checklist (ASC)31 was used
as an outcome measure in a number of studies.
Cognitive behavioural therapy26 resulted in a
signiﬁcant improvement in the intervention group
compared to the control group for the sub-
categories of obstruction (P ¼ 0:04), fatigue
(Po0:001) and irritation (P ¼ 0:03) but not for
dyspnoea, hyperventilation and anxiety.
Lung function
A number of studies included lung function as an
outcome to measure the effectiveness of their
intervention. Seven of these16–19,21,22,29 used a
form of relaxation as the intervention. A meta-
analysis including three of these studies16,18,20
could be performed indicating no signiﬁcant differ-
ence in favour of relaxation therapy for forced
expired volume in 1 s (FEV1) (SMD 0.01, CI 0.41
to 0.40) (Fig. 2).
Lehrer23 and Lehrer24 used bio-feedback therapy
and presented peak expiratory ﬂow (PEF) outcome
data that could be pooled for a meta-analysis. This
indicated a signiﬁcant difference in favour of bio-
feedback therapy (SMD 0.66, CI 0.09–1.23) (Fig. 3).Figure 2
Figure 3Hockemeyer and Smyth21 measured FEV1/FVC
(forced vital capacity ratio) following relaxation
and found a statistically signiﬁcant improvement in
the intervention group mean 102.0 compared to
the control mean 93.7 (Fð1; 54Þ ¼ 4:57, P ¼ 0:038).
The predicted FEV1% was also measured by Hock-
emeyer and Smyth,21 no statistically signiﬁcant
improvement was found in the intervention group
mean 111.5 compared to the control mean 99.8
(Fð1; 54Þ ¼ 3:41, P ¼ 0:71). Payette25 also found no
signiﬁcant differences between groups for FVC,
FEV1, FEV1/FVC after biofeedback training.Medication use
Six studies examined intervention effects on
medication use.15,16,18,23,24,29 A pooled effect from
two studies16,29 demonstrated a positive response
to relaxation treatment by decreasing use of
medication (OR 4.47, CI 1.22–16.44) (Fig. 4). This
translates to a number needed to treat of 3 (95% CI
2–28). Deter and Allert,15 using relaxation, found a
signiﬁcant difference in the numbers of people in
the experimental group (n ¼ 4) who required less
bronchodilators when compared to the control
(n ¼ 0; Po0:05).Absenteeism from school/work
School/work absences were signiﬁcantly decreased
post-intervention for both the asthma rehabilita-
tion group and the control group (data to supportFEV1.
PEF.
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Figure 4 Medication decrease or discontinuation.
Psychological interventions for adults with asthma 11this are not provided, apart from Po0:05) in one
study.28
Psychological health status
Anxiety. Anxiety was used as an outcome measure
in a number of studies using a variety of interven-
tions and measurement techniques.
Anxiety was measured using the State-trait
Anxiety Inventory32 by Epstein et al.16 A narrative
report of no signiﬁcant difference between the
groups was provided. Following author correspon-
dence, data was provided for Trait Anxiety (inter-
vention mean 42.0, SD 13.11 and control mean
38.63, SD 11.90) and State Anxiety (intervention
mean 39.09, SD 13.0 and control mean 42.85, SD
15.24).
Anxiety is a sub-scale on the ASC31 used by Put26
following CBT. No signiﬁcant differences between
groups were found. Ross27 measured anxiety using a
panic attack diary, the Sheehan Patient-Rated
Anxiety Scale (SPRAS)33 and the Anxiety Sensitivity
Index (ASI).34
Depression. Two studies used the Beck Depression
Inventory (BDI)35 as an outcome.16,27 Epstein
et al.16 provided a narrative description of no
statistical difference between groups (means
and SDs were provided following author correspon-
dence for the BDI (intervention group: mean
7.84, SD 6.98 and control group: mean 7.0, SD
6.74)). Ross et al.27 examined the effects of CBT
and found that the results of 2 2 ANOVA analysis
demonstrated no statistical improvement in BDI
levels (Fð1:22Þ ¼ 2:94, Po0:10) between the two
groups (except for external chance (Po0:03) in the
control group).
Health locus of control. Health locus of control,
including internal beliefs, and external control
through powerful others and chance was measured
using the Health Locus of Control Scale36 in a study
investigating the effects of CBT.28 There were no
signiﬁcant differences between baseline and 1 year
follow-up in the intervention group or control
group.A negative emotionality scale, which incorpo-
rates measures of negative affectivity as a person-
ality trait, including irritability, nervousness, and
emotional instability was used by Put et al.26
People in the experimental group had a signiﬁcant
decrease in scores compared to the control group
(Fð2; 42Þ ¼ 10:8, P ¼ 0:0002).
Hockemeyer and Smyth21 measured participant
stress levels using the Perceived Stress Scale37
ANCOVA (controlling for age, age at diagnosis, and
perceived stress levels at baseline) did not reveal
any signiﬁcant differences between groups in
perceived stress levels at the end of a 4 week
CBT programme (Fð1; 54Þ ¼ 1:48, P ¼ 0:23).
Patient satisfaction
Ross et al.27 assessed participant satisfaction with
their CBT programme using a scale of 1–4.
Participants’ mean (SD) ratings of their satisfaction
are recorded in Fig. 5. Hockemeyer and Smyth21
assessed participant satisfaction with a self-deliv-
ered workbook on relaxation, CBT exercises, and
writing therapy. This was assessed using a pre-
developed tool.38 A greater satisfaction with
therapy was found in the intervention group mean
33.73 (SD 6.91) compared to the placebo group
mean 26.67 (SD 9.03) (Po0:01).
Withdrawals
Data relating to drop-outs was provided by seven
studies.16–18,21,24,26,28 A pooled effect for partici-
pant withdrawals was performed for relaxa-
tion16–18,21 which demonstrated no signiﬁcant
difference between the intervention group and
control group (OR 0.67, CI 0.32–1.38) (Fig. 5).
Other withdrawal rates are provided in Fig. 5.Discussion
This systematic review evaluated 14 trials of varied
psychological interventions for adults with asthma.
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Figure 5 Withdrawals.
J. Yorke et al.12The ability to make ﬁrm conclusions as to the
effectiveness of psychological interventions was
limited by poor study quality, insufﬁcient reporting
of data and varied outcome measures. In addition,
the psychological interventions themselves were
varied, did not necessarily have a clear theoretical
underpinning, and were not always well described.
Additionally, the origin of the need for psychologi-
cal intervention was rarely described making it
difﬁcult to discern whether the aim of treatment
was for general adjustment to asthma or for
psychological co-morbidity. Whilst psychological
co-morbidity is recognised as being difﬁcult to
characterise and often not diagnosed,9 it is
imperative that studies evaluating the effects of
psychological interventions deﬁne this character-
istic as the aims and objectives will be different
for each patient group. As such, any results and
conclusions must be viewed with caution. These
issues were also apparent in a recent review
of psychological interventions for children with
asthma.8
Some meta-analyses were performed which gen-
erally showed positive results. For instance, quality
of life, as measured by the AQLA,30 was improved
following CBT. This is an important ﬁnding that
requires further research in this patient population.
Quality of life is an important outcome measure in
patients with respiratory disease as whilst many
interventions may not signiﬁcantly improve physio-
logical parameters, they have been found to cause
a meaningful improvement in the patient, such as
quality of life.40 Further use of the AQLQ would be
beneﬁcial in assessing the effect of CBT and other
psychological interventions on this outcome. A
recently published RCT6 examining the effects of
a nurse-led psycho-educational intervention also
measured quality of life. This paper concluded that
treatment had a positive effect on quality of life
but not physical functioning, symptom control, and
other variables. However, the main component of
the intervention in this RCT was educational and
therefore not included in our systematic review.The ASC31 was also adopted more than once as an
outcome measure.18,21,29 Whilst these studies used
relaxation therapy no meta-analysis could be
performed due to small sample sizes29 and the
presentation of within group analysis only.18 As
such, no conclusion as to the beneﬁts of relaxation
therapy on the ASC outcomes can be provided.
Future use of the ASC is recommended to enable
the effectiveness of varied psychological interven-
tions to be assessed using meta-analyses.
Health care utilisation is increasingly being used
as a primary outcome in drug trials and other
studies on patients with asthma. This being the
case, the primary outcome of this review reﬂects
this. However, few trials included in this review
measured health care use. In addition, it is assumed
that self-report measures were used, and these may
not give accurate data. As stated in a similar review
involving children,8 health care utilisation is an
important indicator of the effect of many interven-
tions as utilisation may be expected to decrease if
there is an improvement in other variables. This
review is unable to make any conclusions as to the
beneﬁt of psychological interventions in reducing
health care utilisation. This outcome needs to be
included in future trials of psychological interven-
tion for adults with asthma.
Lung function was measured as an outcome in a
number of studies and two separate meta-analyses
were performed. Although bio-feedback was found
to improve PEF signiﬁcantly, relaxation therapy did
not have such an impact on FEV1. Whilst lung
function results are valuable in the assessment of
clinical variables, the relationship between these
and psycho-social variables remains questionable.39
The psychological outcomes examined were
numerous and diverse and there seems to be no
consensus as to which psychological outcomes are
conceptually linked to asthma or to the psycholo-
gical interventions being studied. The interventions
used varied as did the anxiety measurement tools.
This prevented any pooled result being analysed. In
addition, depression was measured using the Beck
ARTICLE IN PRESS
Psychological interventions for adults with asthma 13Depression Inventory35 by two studies however;
one used relaxation as the intervention13 and the
other CBT.27
As highlighted in the similar review for children8
the aim of holistically orientated asthma manage-
ment, incorporating psychological interventions, is
not solely to affect health in itself, but rather to
facilitate the patient’s adjustment to the illness37
which should include coping. The coping style of
patients is an important predictor of asthma
morbidity.40 With increasing emphasis on patient
self-management of asthma10 coping should be
considered as an outcome measure for trials of
psychological interventions. We, therefore recom-
mend that valid outcome measures for evaluating
the effectiveness of psychological interventions for
adults with asthma need to address adjustment to
and coping with asthma, as well as other psycho-
logical indicators such as anxiety, depression,
behaviour change, and quality of life.Reviewers conclusions
This review highlights that the effects of psycholo-
gical interventions are difﬁcult to investigate and
present challenges for the design of good RCTs.
Researchers have to recruit sufﬁcient numbers of
subjects to show an effect if there is one, ensure
appropriate randomisation and blinding techniques,
and follow up subjects for a reasonable period.
RCTs evaluating this area are diverse. They study
a mixed group of psychological techniques, which
are difﬁcult to classify due to the different methods
used to deliver the intervention. This resulted in
heterogeneous interventions even when the tech-
nique was given the same classiﬁcation by study
authors. The diversity of the interventions was also
complicated by a multiplicity of outcomes and the
tools used to measure these. In addition, this
review highlights the need to classify patients
according to the presence or absence of psycholo-
gical co-morbidity. We recommend that studies
evaluating the effects of psychological interven-
tions state the origin of the need for treatment as
these two different approaches have different
study aims and objectives.
In addition, this body of work does not seem to
have a clear direction where current work is
inﬂuenced by previous studies. Most of these
studies were done by trialists who, with the
exception of Lehrer’s team, did only one study.
Research funding should target a range of good
quality research, including well-designed RCTs, to
determine the effectiveness and cost effectivenessof psychological techniques that have a sound
theoretical base, with common taxonomy and
outcome indicators. As evidenced by this review,
no recommendations for clinical practise as to the
efﬁcacy of psychological interventions for asthma
can be made. However, the mention of these non-
pharmacological options in international guide-
lines for the management of asthma may act as a
stimulus to research in this area.Acknowledgements
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